Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 11 (2011), Pages 283-288
http://dx.doi.org/10.1100/tsw.2011.29
Review Article

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer

Memorial Sloan-Kettering Cancer Center, New York, USA

Received 17 September 2010; Revised 1 November 2010; Accepted 22 December 2010

Academic Editor: Karim Kader

Copyright © 2011 Harry W. Herr.

Citations to this Article [17 citations]

The following is the list of published articles that have cited the current article.

  • Johannes Falke, and J. Alfred Witjes, “Perioperative management of nonmuscle-invasive bladder cancer,” Current Opinion in Urology, vol. 21, no. 5, pp. 403–408, 2011. View at Publisher · View at Google Scholar
  • Prashant Patel, Richard T. Bryan, and D. Michael A. Wallace, “Emerging Endoscopic and Photodynamic Techniques for Bladder Cancer Detection and Surveillance,” The Scientific World JOURNAL, vol. 11, pp. 2550–2558, 2011. View at Publisher · View at Google Scholar
  • Sten Holmäng, “ High-grade non-muscle-invasive bladder cancer: Is re-resection necessary in all patients before intravesical bacillus Calmette–Guérin treatment? ,” Scandinavian Journal of Urology, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • Christine Gan, Amit Patel, Sarah Fowler, James Catto, Derek Rosario, and Timothy O'Brien, “Snapshot of transurethral resection of bladder tumours in the United Kingdom Audit (STUKA),” Bju International, vol. 112, no. 7, pp. 930–935, 2013. View at Publisher · View at Google Scholar
  • Yang, Cai, and Zhang, “Second transurethral resection of bladder tumour for the treatment of muscleinvasive bladder tumours,” West Indian Medical Journal, vol. 62, no. 9, pp. 839–843, 2013. View at Publisher · View at Google Scholar
  • Alejandro Sousa, Brant A. Inman, Idelfonso Piñeiro, Victor Monserrat, Alberto Pérez, Vincente Aparici, Isabel Gómez, Pilar Neira, and Carlos Uribarri, “A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer,” International Journal of Hyperthermia, pp. 1–5, 2014. View at Publisher · View at Google Scholar
  • Daniel J. Canter, Louis M. Revenig, Zachary L. Smith, Ryan W. Dobbs, S. Bruce Malkowicz, Muta M. Issa, and Thomas J. Guzzo, “Re-examination of the Natural History of High-grade T1 Bladder Cancer using a Large Contemporary Cohort,” International Braz J Urol, vol. 40, no. 2, pp. 172–178, 2014. View at Publisher · View at Google Scholar
  • Kyle A. Richards, Norm D. Smith, and Gary D. Steinberg, “The Importance of Transurethral Resection of Bladder Tumor in the Management of Nonmuscle Invasive Bladder Cancer: A Systematic Review of Novel Technologies,” The Journal of Urology, 2014. View at Publisher · View at Google Scholar
  • Robert S. Svatek, Brent K. Hollenbeck, Sten Holmäng, Richard Lee, Simon P. Kim, Arnulf Stenzl, and Yair Lotan, “The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease,” European Urology, 2014. View at Publisher · View at Google Scholar
  • David A. Lazica, Stephan Roth, Alexander S. Brandt, Stefanie Boettcher, Michael J. Mathers, and Burkhard Ubrig, “Second Transurethral Resection after Ta High-Grade Bladder Tumor: A 4.5-Year Period at a Single University Center,” Urologia Internationalis, vol. 92, no. 2, pp. 131–135, 2014. View at Publisher · View at Google Scholar
  • Michael Jurewicz, and Mark S. Soloway, “Approaching the optimal transurethral resection of a bladder tumor,” Turk Uroloji Dergisi, vol. 40, no. 2, pp. 73–77, 2014. View at Publisher · View at Google Scholar
  • Mohamed Bishr, Jean-Baptiste Lattouf, Mathieu Latour, and Fred Saad, “Tumour stage on re-staging transurethral resection predicts recurrence and progression-free survival of patients with high-risk non-muscle invasive bladder cancer,” Journal of the Canadian Urological Association, vol. 8, no. 5-6, pp. e306–e310, 2014. View at Publisher · View at Google Scholar
  • Harry W. Herr, “Role of repeat resection in non-muscle-invasive bladder cancer,” JNCCN Journal of the National Comprehensive Cancer Network, vol. 13, no. 8, pp. 1041–1046, 2015. View at Publisher · View at Google Scholar
  • Takuya Koie, Chikara Ohyama, Shogo Hosogoe, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, and Kazuyuki Mori, “Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer,” International Urology and Nephrology, 2015. View at Publisher · View at Google Scholar
  • Paolo Gontero, Richard Sylvester, Francesca Pisano, Steven Joniau, Marco Oderda, Vincenzo Serretta, Stéphane Larré, Savino Di Stasi, Bas Van Rhijn, Alfred J. Witjes, Anne J. Grotenhuis, Renzo Colombo, Alberto Briganti, Marek Babjuk, Viktor Soukup, Per-Uno Malmström, Jacques Irani, Nuria Malats, Jack Baniel, Roy Mano, Tommaso Cai, Eugene K. Cha, Peter Ardelt, John Vakarakis, Riccardo Bartoletti, Guido Dalbagni, Shahrokh F. Shariat, Evanguelos Xylinas, Robert J. Karnes, and Joan Palou, “The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin,” BJU International, 2015. View at Publisher · View at Google Scholar
  • Patrick C. Gordon, Francis Thomas, Aidan P. Noon, Derek J. Rosario, and James W.F. Catto, “Long-term Outcomes from Re-resection for High-risk Non–muscle-invasive Bladder Cancer: A Potential to Rationalize Use,” European Urology Focus, 2017. View at Publisher · View at Google Scholar
  • Matthew Mossanen, Steven L. Chang, Simon Kimm, Guru P. Sonpavde, and Adam S. Kibel, “Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma,” Urologic Clinics of North America, vol. 45, no. 2, pp. 143–154, 2018. View at Publisher · View at Google Scholar